Additionally, elevated c-Myc expression was also observed in higher-risk MDS patients, and in vitro experiments and microarray analyses indicated that RPL23 knockdown was potentially associated with decreased c-Myc expression as well as suppressed PI3K/AKT signalling. The gene discussed is RPL23; the disease is myelodysplastic syndrome.